[
  {
    "ts": "2026-02-06T01:06:23+00:00",
    "headline": "Adaptive Biotechnologies Q4 Earnings Call Highlights",
    "summary": "Adaptive Biotechnologies (NASDAQ:ADPT) executives said the company delivered “remarkable” performance in 2025, driven by sharp growth and improving profitability in its minimal residual disease (MRD) franchise and early monetization steps in its Immune Medicine (IM) data platform. On the company’s",
    "url": "https://www.marketbeat.com/instant-alerts/adaptive-biotechnologies-q4-earnings-call-highlights-2026-02-05/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "a8cf2ff9-b58e-37ae-8816-3c471940f077",
      "content": {
        "id": "a8cf2ff9-b58e-37ae-8816-3c471940f077",
        "contentType": "STORY",
        "title": "Adaptive Biotechnologies Q4 Earnings Call Highlights",
        "description": "",
        "summary": "Adaptive Biotechnologies (NASDAQ:ADPT) executives said the company delivered “remarkable” performance in 2025, driven by sharp growth and improving profitability in its minimal residual disease (MRD) franchise and early monetization steps in its Immune Medicine (IM) data platform. On the company’s",
        "pubDate": "2026-02-06T01:06:23Z",
        "displayTime": "2026-02-06T01:06:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/baa5b0d6d1008ef08fbab74e80859778",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "Adaptive Biotechnologies logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vl3KxAbO6Qy1kY4gwcWiQw--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/baa5b0d6d1008ef08fbab74e80859778.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/k0aX39WhsUnMUyzB.8sxJg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/baa5b0d6d1008ef08fbab74e80859778.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/instant-alerts/adaptive-biotechnologies-q4-earnings-call-highlights-2026-02-05/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/adaptive-biotechnologies-q4-earnings-call-010623027.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ADPT"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-06T00:44:00+00:00",
    "headline": "GoodRx Powers Pricing for Leading Brand Medications on TrumpRx",
    "summary": "SANTA MONICA, Calif., February 06, 2026--GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced that it is a key integration partner for pharmaceutical companies offering discounted cash prices on TrumpRx.",
    "url": "https://finance.yahoo.com/news/goodrx-powers-pricing-leading-brand-004400420.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "00e228a0-babb-37d2-aaa3-52d6fa9a6740",
      "content": {
        "id": "00e228a0-babb-37d2-aaa3-52d6fa9a6740",
        "contentType": "STORY",
        "title": "GoodRx Powers Pricing for Leading Brand Medications on TrumpRx",
        "description": "",
        "summary": "SANTA MONICA, Calif., February 06, 2026--GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced that it is a key integration partner for pharmaceutical companies offering discounted cash prices on TrumpRx.",
        "pubDate": "2026-02-06T00:44:00Z",
        "displayTime": "2026-02-06T00:44:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/2a0392dcd49ff160de74bfa4a5939cac",
          "originalWidth": 480,
          "originalHeight": 389,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wNs0g3oc_MquhuCBEiO_aQ--~B/aD0zODk7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/2a0392dcd49ff160de74bfa4a5939cac.cf.webp",
              "width": 480,
              "height": 389,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.ei1HC_Ufmp6e0tYSCB8qA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/2a0392dcd49ff160de74bfa4a5939cac.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/goodrx-powers-pricing-leading-brand-004400420.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/goodrx-powers-pricing-leading-brand-004400420.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "GDRX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-06T00:09:00+00:00",
    "headline": "Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans",
    "summary": "NEW YORK, February 06, 2026--Pfizer Inc. (NYSE: PFE) today announced the launch of its program on TrumpRx, making innovative medicines more affordable and accessible to millions of Americans. Starting today, the program provides Americans a wide range of more than 30 medicines at a significant discount off list prices. This effort is part of Pfizer’s broader landmark Most Favored Nation (MFN) agreement with the U.S. government enabling patients to pay lower prices for their prescription medicine",
    "url": "https://finance.yahoo.com/news/pfizer-launches-cost-savings-program-000900467.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "0ebd13bc-61af-3591-8f06-40c4675a62a9",
      "content": {
        "id": "0ebd13bc-61af-3591-8f06-40c4675a62a9",
        "contentType": "STORY",
        "title": "Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans",
        "description": "",
        "summary": "NEW YORK, February 06, 2026--Pfizer Inc. (NYSE: PFE) today announced the launch of its program on TrumpRx, making innovative medicines more affordable and accessible to millions of Americans. Starting today, the program provides Americans a wide range of more than 30 medicines at a significant discount off list prices. This effort is part of Pfizer’s broader landmark Most Favored Nation (MFN) agreement with the U.S. government enabling patients to pay lower prices for their prescription medicine",
        "pubDate": "2026-02-06T00:09:00Z",
        "displayTime": "2026-02-06T00:09:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/162e33c14a423d5d5ba8304ba1133c54",
          "originalWidth": 480,
          "originalHeight": 212,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NIkdbJYkUviiZ8kEF2uOfQ--~B/aD0yMTI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/162e33c14a423d5d5ba8304ba1133c54.cf.webp",
              "width": 480,
              "height": 212,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TS7C5w3sgbNtvl6lOubJ4g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/162e33c14a423d5d5ba8304ba1133c54.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-launches-cost-savings-program-000900467.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-launches-cost-savings-program-000900467.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]